2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

The Associations Between Body Mass Index and Kidney Transplant Outcomes Are Mediated by Weight-Adjusted Immunosuppression Dosing.

K. Flabouris,^1,2 S. Chadban,^1,3,4 M. Ladhani,^1,3,5 M. Cervelli,⁶ P. Clayton.^1,2,6
The Associations Between Immunosuppression Use, Loss of Medicare and Kidney Allograft Outcomes.

A. Hart,^1,2 S. Gustafson,² A. Wey,² N. Hadley,² A. Israni.²
The Beneficial Effect of Janus Kinase 3 Inhibitor on Transplanted Islet via Protection from Oxidative Stress-Induced β Cell Death.

S.-J. Kang,^1,2,3,4 H. Chung,^1,2,3,4 S. Lee,^1,2,3,4 J.-S. Shin,^1,3,5 H.-J. Kim,^1,2,3,4 J.-M. Kim,^1,3,5 B.-H. Min,^1,3,5 S. Choi,^1,2,3,4 C.-G. Park.^1,2,3,4,5
The Beneficial Effects of mTOR Inhibitors on Liver Resident Natural Killer Cells.

J. Saparbay, Y. Tanaka, T. Yano, H. Ohdan.
The Benefits of Pancreas After Kidney (PAK) Transplantation.

M. Curry,¹ J. Odorico,² J. Fridell.³
The Clinical and Economic Burden of Pneumonia in Canadian Solid Organ Transplant Recipients.

N. Law,¹ B. Hamandi,² A. Alghamdi,¹ E. Papadimitropoulos,² S. Husain.¹
The Clinical Significance of Red Cell Distribution Width (RDW) in Kidney Transplant Recipients.

S. Park,¹ J. Ha,¹ Y. Kim,¹ H. Lee,¹ Y. Kim,¹ C. Lim,¹ I. Jung,¹ D.-J. Han,² S.-K. Park,² Y. Kim,² J. Lee.¹
The Combined Effects of Induction Regimens and Antiviral Prophylaxis on the Risk of CMV Infection in Different Serostatus Subgroups After Liver Transplantation.

C. Low,² S. Hosseini-Moghaddam,^1,2 C. Rotstein,² E. Renner,² A. Humar,² D. Kumar,² S. Husain.²
The Cumulative United States Experience with Transplants (Txs) from Living Donors (LDs): 140,156 LD Txs in 28 Years.

R. Gruessner,¹ M. Laftavi,¹ V. Whittaker,¹ O. Pankwycz,² Z. Acun,¹ A. Gruessner.¹
The Degree of NK Cell Activation Determines the Ability of Donor-Specific Antibodies to Mediate Acute vs. Chronic Rejection of Kidney Allografts.

T. Yagisawa,^1,2 T. Tanaka,¹ N. Dvorina,¹ A. Valujskikh,¹ W. Baldwin 3rd,¹ R. Fairchild.¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z